These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 5478542)

  • 41. The influence of age, height, and body weight on cerebrospinal fluid amine metabolites and tryptophan in women.
    Banki CM; Molnar G
    Biol Psychiatry; 1981 Aug; 16(8):753-62. PubMed ID: 6169376
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cerebrospinal fluid amine metabolites and cyclic nucleotides in human aggression [proceedings].
    Brown GL; Goodwin FK; Ballenger JC; Goyer PF
    Psychopharmacol Bull; 1981 Jan; 17(1):63-5. PubMed ID: 6165032
    [No Abstract]   [Full Text] [Related]  

  • 43. 5-Hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer's disease, depression and mild cognitive impairment.
    Stuerenburg HJ; Ganzer S; Müller-Thomsen T
    Neuro Endocrinol Lett; 2004 Dec; 25(6):435-7. PubMed ID: 15665806
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acid monoamine metabolites in cerebrospinal fluid during methadone maintenance.
    Bowers MB; Kleber HD; Davis L
    Nature; 1971 Aug; 232(5312):581-2. PubMed ID: 4937511
    [No Abstract]   [Full Text] [Related]  

  • 45. [Evaluation of intellectual functions in patients with Parkinson's disease. Bibliographic review].
    Piccirilli M; Piccinin GL; Lamedica A
    Riv Patol Nerv Ment; 1981; 101(5):225-46. PubMed ID: 6172833
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of nafronyl on lactate and pyruvate in the cerebrospinal fluid of patients with senile dementia.
    Yesavage JA; Tinklenberg JR; Hollister LE; Berger PA
    J Am Geriatr Soc; 1982 Feb; 30(2):105-8. PubMed ID: 6173407
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Behavioral manifestations of movement disorders. Parkinson's and Huntington's disease.
    Mayeux R
    Neurol Clin; 1984 Aug; 2(3):527-40. PubMed ID: 6085395
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acid monoamine metabolites in human cerebrospinal fluid and their relations to age and sex.
    Gottfries CG; Gottfries I; Johansson B; Olsson R; Persson T; Roos BE; Sjöström R
    Neuropharmacology; 1971 Nov; 10(6):665-72. PubMed ID: 5128025
    [No Abstract]   [Full Text] [Related]  

  • 49. 5-Hydroxyindoleacetic acid in cerebrospinal fluid.
    Molnár G; Fodor A; Karczag I; Szilágyi A; Ujvárosi I
    Acta Med Acad Sci Hung; 1973; 30(3):211-7. PubMed ID: 4785998
    [No Abstract]   [Full Text] [Related]  

  • 50. Ventricular fluid 5-hydroxyindoleacetic acid concentrations during human sleep.
    Wyatt RJ; Neff NH; Vaughan T; Franz J; Ommaya A
    Adv Biochem Psychopharmacol; 1974; 11(0):193-7. PubMed ID: 4367645
    [No Abstract]   [Full Text] [Related]  

  • 51. Measurement of acid monoamine metabolites in human and animal cerebrospinal fluid.
    Gerbode FA; Bowers MB
    J Neurochem; 1968 Sep; 15(9):1053-5. PubMed ID: 5682508
    [No Abstract]   [Full Text] [Related]  

  • 52. Huntington's chorea. Effect of serotonin depletion.
    Chase TN; Watanabe AM; Brodie KH; Donnelly EF
    Arch Neurol; 1972 Mar; 26(3):282-4. PubMed ID: 4258630
    [No Abstract]   [Full Text] [Related]  

  • 53. [Clinical pharmacology (11): diagnostic methods].
    Roos BE
    Lakartidningen; 1970 Apr; 67(18):2032-5. PubMed ID: 5450542
    [No Abstract]   [Full Text] [Related]  

  • 54. [Circadian determination of 5-hydroxyindoleacetic acid in human cerebrospinal fluid].
    Nicoletti F; Cambria A; Raffaele R; Grasso AM; Falsaperla A
    Boll Soc Ital Biol Sper; 1978 Mar; 54(6):497-502. PubMed ID: 743464
    [No Abstract]   [Full Text] [Related]  

  • 55. [Diagnostic problems in senile and presenile dementia].
    Brotto M; Provini A
    Acta Gerontol (Milano); 1969; 19(1):37-53. PubMed ID: 5397229
    [No Abstract]   [Full Text] [Related]  

  • 56. [Cerebrospinal fluid examinations of aged patients using electrophysical methods (proceedings)].
    Nordqvist P; Arwin H; Lundström L
    Aktuelle Gerontol; 1978 Oct; 8(10):546-7. PubMed ID: 30307
    [No Abstract]   [Full Text] [Related]  

  • 57. Monoamine neurons in aging and Alzheimer's disease.
    Palmer AM; DeKosky ST
    J Neural Transm Gen Sect; 1993; 91(2-3):135-59. PubMed ID: 8099796
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.
    Palmer AM; Sims NR; Bowen DM; Neary D; Palo J; Wikstrom J; Davison AN
    J Neurol Neurosurg Psychiatry; 1984 May; 47(5):481-4. PubMed ID: 6204017
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.
    Brogden RN; Speight TM; Avery GS
    Drugs; 1971; 2(4):262-400. PubMed ID: 4340597
    [No Abstract]   [Full Text] [Related]  

  • 60. The development of the pathologic changes of Alzheimer's disease and senile dementia in patients with Down's syndrome.
    Burger PC; Vogel FS
    Am J Pathol; 1973 Nov; 73(2):457-76. PubMed ID: 4271339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.